The overall objective of this contract is to advance the development of the frontlineodp(TM) system for producing a point of care plasma product for transfusion. The scope is defined in the SOW below.

Active Definitive Contract Awarded Last action

Contract number
75A50121C00059
Awardee
Awarding agency
Obligated
$139,001,591

Award facts

Opportunity
  • BAA18100SOL0003 Solicitation number
Contract value 89% obligated
  • $139,001,591.00 Current, with exercised options
  • $156,726,618.00 Potential, with all options
Completion date 51% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Beverly, MA 01915, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00021 · The purpose of this modification is to provide supplemental funding for clins 0005, 0006, 0008, update articles b.2.2. Option costs, b.3. Advanced… $3,394,355
Other Administrative Action P00020 · The purpose of this administrative modification is to correct the period of performance for clins 0001, 0004, 0005, 0006, 0007, 0008, and 0009 to align with… $0
Other Administrative Action P00019 · The purpose of this modification is to update article b.3 advanced understanding, item 6. Subcontracts and consultants, and the statement of work dated april… $0
Other Administrative Action P00018 · Far part 43.103 - uniateral modification $0
Exercise an Option P00017 · Far part 43.103(a) - bilateral modification $34,997,895
Other Administrative Action P00015 · The purpose of this no-cost extension modification is to extend the period of performance through february 28, 2026, for clin 0008/option 7 for the completion… $0
Funding Only Action P00014 · The purpose of this modification is to provide supplemental funding for clins 0001, 0005, 0008, 0009, extend the period of performance through june 30, 2026,… $3,299,853
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 · The purpose of this no-cost extension modification is to extend the period of performance (POP) of clin 0001 (base) to 6/30/2025, clin 0002 (option 1) to… $0
Other Administrative Action P00010 · The purpose of this modification is to correct the period of performance to align IPP for CLIN0005 (option 4). $0
Exercise an Option P00009 · The purpose of this modification is to exercise and fund option 8/CLIN0009, provide supplemental funding for clins 0001, 0002, 0003, 0004, 0005, update SOW… $13,874,402
Other Administrative Action P00008 $0
Other Administrative Action P00007 · The purpose of this no-cost extension modification is to extend the period of performance (POP) of clin 0002 (option 1) to 3/30/2024, clin 0003 (option 2) to… $0
Supplemental Agreement for work within scope P00006 $2,799,920
Exercise an Option P00005 $41,250,746
Supplemental Agreement for work within scope P00004 $2,923,468
Change Order P00003 $4,751,419
Exercise an Option P00002 $11,772,214
Original award $19,937,319
Show all 20

About this award

The Office of the Assistant Secretary for Preparedness and Response awarded a $156.7 million definitive contract to Velico Medical, Inc. for advanced development of the FrontlineODP™ system, a point-of-care plasma product for transfusion, on August 2, 2021, with an ultimate completion date of November 30, 2031.

The contract is cost-plus-fixed-fee with no set-aside. Place of performance is Beverly, Massachusetts. This modification provides supplemental funding for CLINs 0005, 0006, and 0008, and updates pricing, advanced understandings, and statement of work provisions dated August 1, 2026.

In fiscal year 2024, the contract generated $27.1 million in government-invoiced labor across 31.1 FTEs and 64,774 contractor hours, reflecting a blended government-paid rate of $418.47 per hour. Velico Medical subcontracted 35 percent of contractor hours to three subcontractors.

Quick answers

Who was awarded contract 75A50121C00059?

75A50121C00059 was awarded to Velico Medical, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 2, 2021.

How much is contract 75A50121C00059 worth?

The government has obligated $139,001,591 on 75A50121C00059. Its potential value, with all options, is $156,726,618.

Was contract 75A50121C00059 competed?

The extent of competition for 75A50121C00059 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award